title: Tobacco cessation for the dental team: a practical guide part II: evidence-based interventions.
abstract: Dental professionals are strategically placed to be the leaders in tobacco prevention and cessation as they provide preventive and therapeutic services to a basically healthy population on a regular basis. By expanding the dental exam, diagnosis, and treatment to include tobacco cessation, a potentially life saving element of care is added to an established service. In addition periodontal disease and the potential for oral cancer mandate the inclusion of tobacco cessation services into dental care. Though dental professionals are aware of the health issues associated with tobacco use, they often feel ill prepared or uncomfortable presenting patients with a clear cessation message. In this, the second of a two-part article, the purpose is to provide dental professionals with the evidence-based strategies necessary to provide effective tobacco cessation as a normal part of patient care.
authors.affiliation: Southern Illinois University, Carbondale, IL, USA.
authors.forename: Joan M
authors.initials: JM
authors.lastname: Davis
mesh_terms: D016642:Bupropion / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D003729:Dental Care; D019317:Evidence-Based Medicine; D006284:Health Plan Implementation; D015277:Hotlines; D006801:Humans; D009042:Motivation; D009538:Nicotine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010174:Pamphlets; D011109:Polymethacrylic Acids / Q000627:therapeutic use; D011145:Polyvinyls / Q000627:therapeutic use; D020340:Tobacco Use Cessation / Q000379:methods*; D061485:Tobacco Use Cessation Devices; D014029:Tobacco Use Disorder / Q000188:drug therapy*
chemical_list: D000697:Central Nervous System Stimulants; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D016642:Bupropion; D009538:Nicotine